121 related articles for article (PubMed ID: 3549595)
1. Effect of cyclospasmol on early diabetic retinopathy.
Mota MC; Leite E; Ruas MA; Verjans HL; Blakemore CB; Cunha-Vaz JG
Int Ophthalmol; 1987 Feb; 10(1):3-9. PubMed ID: 3549595
[TBL] [Abstract][Full Text] [Related]
2. Treatment of early diabetic retinopathy with cyclandelate.
Cunha-Vaz JG; Reis Fonseca J; Hagenouw JR
Br J Ophthalmol; 1977 Jun; 61(6):399-404. PubMed ID: 326306
[TBL] [Abstract][Full Text] [Related]
3. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
[TBL] [Abstract][Full Text] [Related]
4. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy.
Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG
Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006
[TBL] [Abstract][Full Text] [Related]
5. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
Bordat B; Guirgis IR; Manderscheid JC
J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
[TBL] [Abstract][Full Text] [Related]
6. Cyclandelate in the treatment of cerebral arteriosclerosis.
Hall P
J Am Geriatr Soc; 1976 Jan; 24(1):41-5. PubMed ID: 811704
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy.
De Leeuw IH; Van Rooy P; Moeremans M; Driessens M
Drugs; 1987; 33 Suppl 2():125-30. PubMed ID: 3304951
[TBL] [Abstract][Full Text] [Related]
8. Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial.
van Gerven JM; Boot JP; Lemkes HH; van Best JA
Doc Ophthalmol; 1994; 87(4):355-65. PubMed ID: 7851219
[TBL] [Abstract][Full Text] [Related]
9. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy.
Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
Diabetes; 1986 May; 35(5):574-8. PubMed ID: 3514333
[TBL] [Abstract][Full Text] [Related]
10. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
[TBL] [Abstract][Full Text] [Related]
11. Effects of Cyclospasmol upon sensory parameters in patients recovering from cerebrovascular accidents.
Sourander L; Blakemore CB
Angiology; 1978 Feb; 29(2):133-8. PubMed ID: 347985
[No Abstract] [Full Text] [Related]
12. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.
Nappi G; Sandrini G; Savoini G; Cavallini A; de Rysky C; Micieli G
Drugs; 1987; 33 Suppl 2():103-9. PubMed ID: 3304950
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.
Albizzati MG; Bassi S; Sbacchi M; Frattola L
Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327
[No Abstract] [Full Text] [Related]
15. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy.
Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D
Retina; 1987; 7(3):170-6. PubMed ID: 3423432
[TBL] [Abstract][Full Text] [Related]
16. [Surveillance using vitreo-fluoro-photometry of diabetics treated with an insulin pump, without or with minimal retinopathy. Results after 3 years].
Bordat B; Misse P; Zaluski S; Rouault R; Mirouze J
J Fr Ophtalmol; 1989; 12(6-7):421-5. PubMed ID: 2636237
[TBL] [Abstract][Full Text] [Related]
17. The effect of buflomedil in diabetic retinopathy estimated by ocular fluorophotometry.
Kjaergaard JJ; Ditzel J
Int J Microcirc Clin Exp; 1987 Aug; 6(3):257-63. PubMed ID: 3308731
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the early stages of diabetic retinopathy by vitreous fluorophotometry.
Cunha-Vaz JG; Gray JR; Zeimer RC; Mota MC; Ishimoto BM; Leite E
Diabetes; 1985 Jan; 34(1):53-9. PubMed ID: 3964755
[TBL] [Abstract][Full Text] [Related]
19. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy.
Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
Arch Ophthalmol; 1985 Sep; 103(9):1307-11. PubMed ID: 2931063
[TBL] [Abstract][Full Text] [Related]
20. Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.
Albizzati MG; Bassi S; Calloni E; Sbacchi M; Piolti R; Frattola L
Drugs; 1987; 33 Suppl 2():90-6. PubMed ID: 3304956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
